Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. Revenue 2020–2025
Arcutis Biotherapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcutis Biotherapeutics Inc. revenue for the quarter ending March 31, 2026 was 105.4 M, a 60.07% increase year-over-year.
- Arcutis Biotherapeutics Inc. revenue for the twelve months ending March 31, 2026 was 352.0 M, a 115.55% increase year-over-year.
- Arcutis Biotherapeutics Inc. annual revenue for 2025 was 376.1 M, a 91.34% increase from 2024.
- Arcutis Biotherapeutics Inc. annual revenue for 2024 was 196.5 M, a 229.74% increase from 2023.
- Arcutis Biotherapeutics Inc. annual revenue for 2023 was 59.6 M, a 1517.09% increase from 2022.
- Arcutis Biotherapeutics Inc. annual revenue for 2022 was 3.7 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Arcutis Biotherapeutics Inc. Revenue — FAQ
Arcutis Biotherapeutics Inc. (ARQT) revenue over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Arcutis Biotherapeutics Inc.'s revenue?
Arcutis Biotherapeutics Inc. (ARQT) reported revenue of $376M for fiscal 2025.
Where can I see ARQT's revenue history?
The chart and table above show Arcutis Biotherapeutics Inc.'s revenue by year and by quarter, including the growth rate.